Related Experiment Video
Updated: Aug 17, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Primary and secondary prevention of stroke by antihypertensive drug treatment
1Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, Ruijin 2nd Road 197, Shanghai 200025, China. jiguangwang@netscape.net
Insights
Antihypertensive drugs significantly reduce stroke incidence. Certain newer medications like calcium-channel blockers and angiotensin receptor blockers offer superior stroke prevention compared to older drugs.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Hypertension is a primary risk factor for stroke.
- Antihypertensive medications are crucial for stroke incidence reduction.
Purpose of the Study:
- To compare the efficacy of different antihypertensive drug classes in stroke prevention.
- To analyze the impact of blood pressure reduction on stroke recurrence.
Main Methods:
- Meta-analysis of actively controlled trials comparing antihypertensive drugs.
- Overview of trials in patients with prior cerebrovascular disease.
- Meta-regression analysis to assess the role of systolic blood pressure differences.
Main Results:
- Angiotensin Type 1 receptor blockers showed significant stroke prevention (-24%).
- Calcium-channel blockers demonstrated a trend towards better stroke prevention.
- Blood pressure-lowering therapy reduced stroke recurrence by 25% in high-risk patients.
- Systolic blood pressure reduction was identified as a key factor in stroke prevention.
Conclusions:
- Certain newer antihypertensive agents offer superior stroke prevention over traditional drugs.
- Effective blood pressure management is critical for preventing stroke recurrence.
Abstract:
Hypertension is the most powerful risk factor for stroke. Antihypertensive drug treatment reduces the incidence of stroke. In a meta-analysis of actively controlled trials, calcium-channel blockers, including (-8%; p = 0.07) or excluding verapamil (-10%; p = 0.02), as well as angiotensin Type 1 receptor blockers (-24%; p = 0.0002) resulted in better stroke prevention than the old drugs (diuretics or beta-blockers), whereas the opposite trend was observed for angiotensin-converting enzyme inhibitors (+10%; p = 0.03). An overview of six trials conducted in patients with a history of cerebrovascular disease demonstrated that blood pressure-lowering therapy reduced stroke recurrence by 25% (p = 0.004). A meta-regression analysis showed that within-trial differences in systolic blood pressure accounted for the prevention of stroke in most trials. This finding was corroborated by the recently published Valsartan Antihypertensive Long-term Use Evaluation trial.
Related Concept Videos
Preventive Healthcare Services
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
